Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation
Left ventricular hypertrophy (LVH) is significantly related to adverse clinical outcomes in patients at high risk of cardiovascular events. In patients with atrial fibrillation (AF), data on LVH, that is, prevalence and determinants, are inconsistent mainly because of different definitions and heter...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 June 2015
|
| In: |
The American journal of cardiology
Year: 2015, Jahrgang: 116, Heft: 6, Pages: 877-882 |
| ISSN: | 1879-1913 |
| DOI: | 10.1016/j.amjcard.2015.05.060 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.amjcard.2015.05.060 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0002914915015283 
|
| Verfasserangaben: | Marco Proietti, MD, Alberto Maria Marra, MD, Eliezer Joseph Tassone, MD, Stefano De Vuono, MD, Salvatore Corrao, MD, Paolo Gobbi, MD, Francesco Perticone, MD, Gino Roberto Corazza, MD, Stefania Basili, MD, Gregory Y. H. Lip, MD, Francesco Violi, MD, and Valeria Raparelli, PhD, on behalf of ARAPACIS Study Investigators, GIS Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 172492611X | ||
| 003 | DE-627 | ||
| 005 | 20240406193241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200716s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amjcard.2015.05.060 |2 doi | |
| 035 | |a (DE-627)172492611X | ||
| 035 | |a (DE-599)KXP172492611X | ||
| 035 | |a (OCoLC)1341345611 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Proietti, Marco |e VerfasserIn |0 (DE-588)1213905745 |0 (DE-627)1724928244 |4 aut | |
| 245 | 1 | 0 | |a Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation |c Marco Proietti, MD, Alberto Maria Marra, MD, Eliezer Joseph Tassone, MD, Stefano De Vuono, MD, Salvatore Corrao, MD, Paolo Gobbi, MD, Francesco Perticone, MD, Gino Roberto Corazza, MD, Stefania Basili, MD, Gregory Y. H. Lip, MD, Francesco Violi, MD, and Valeria Raparelli, PhD, on behalf of ARAPACIS Study Investigators, GIS Group |
| 264 | 1 | |c 25 June 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.07.2020 | ||
| 520 | |a Left ventricular hypertrophy (LVH) is significantly related to adverse clinical outcomes in patients at high risk of cardiovascular events. In patients with atrial fibrillation (AF), data on LVH, that is, prevalence and determinants, are inconsistent mainly because of different definitions and heterogeneity of study populations. We determined echocardiographic-based LVH prevalence and clinical factors independently associated with its development in a prospective cohort of patients with non-valvular (NV) AF. From the “Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study” (ARAPACIS) population, 1,184 patients with NVAF (mean age 72 ± 11 years; 56% men) with complete data to define LVH were selected. ARAPACIS is a multicenter, observational, prospective, longitudinal on-going study designed to estimate prevalence of peripheral artery disease in patients with NVAF. We found a high prevalence of LVH (52%) in patients with NVAF. Compared to those without LVH, patients with AF with LVH were older and had a higher prevalence of hypertension, diabetes, and previous myocardial infarction (MI). A higher prevalence of ankle-brachial index ≤0.90 was seen in patients with LVH (22 vs 17%, p = 0.0392). Patients with LVH were at significantly higher thromboembolic risk, with CHA2DS2-VASc ≥2 seen in 93% of LVH and in 73% of patients without LVH (p <0.05). Women with LVH had a higher prevalence of concentric hypertrophy than men (46% vs 29%, p = 0.0003). Logistic regression analysis demonstrated that female gender (odds ratio [OR] 2.80, p <0.0001), age (OR 1.03 per year, p <0.001), hypertension (OR 2.30, p <0.001), diabetes (OR 1.62, p = 0.004), and previous MI (OR 1.96, p = 0.001) were independently associated with LVH. In conclusion, patients with NVAF have a high prevalence of LVH, which is related to female gender, older age, hypertension, and previous MI. These patients are at high thromboembolic risk and deserve a holistic approach to cardiovascular prevention. | ||
| 700 | 1 | |a Marra, Alberto M. |d 1983- |e VerfasserIn |0 (DE-588)1120443504 |0 (DE-627)873382676 |0 (DE-576)480349045 |4 aut | |
| 700 | 1 | |a Tassone, Eliezer Joseph |e VerfasserIn |4 aut | |
| 700 | 1 | |a De Vuono, Stefano |e VerfasserIn |4 aut | |
| 700 | 1 | |a Corrao, Salvatore |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gobbi, Paolo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Perticone, Francesco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Corazza, Gino Roberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Basili, Stefania |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lip, Gregory Y. H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Violi, Francesco |e VerfasserIn |0 (DE-588)1234715791 |0 (DE-627)175978589X |4 aut | |
| 700 | 1 | |a Raparelli, Valeria |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of cardiology |d Amsterdam [u.a.] : Elsevier, 1958 |g 116(2015), 6, Seite 877-882 |h Online-Ressource |w (DE-627)320596249 |w (DE-600)2019595-3 |w (DE-576)10963392X |x 1879-1913 |7 nnas |a Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation |
| 773 | 1 | 8 | |g volume:116 |g year:2015 |g number:6 |g pages:877-882 |g extent:6 |a Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.amjcard.2015.05.060 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0002914915015283 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200716 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1120443504 |a Marra, Alberto M. |m 1120443504:Marra, Alberto M. |p 2 | ||
| 999 | |a KXP-PPN172492611X |e 3724639848 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Marco Proietti, MD, Alberto Maria Marra, MD, Eliezer Joseph Tassone, MD, Stefano De Vuono, MD, Salvatore Corrao, MD, Paolo Gobbi, MD, Francesco Perticone, MD, Gino Roberto Corazza, MD, Stefania Basili, MD, Gregory Y. H. Lip, MD, Francesco Violi, MD, and Valeria Raparelli, PhD, on behalf of ARAPACIS Study Investigators, GIS Group"]},"origin":[{"dateIssuedDisp":"25 June 2015","dateIssuedKey":"2015"}],"id":{"eki":["172492611X"],"doi":["10.1016/j.amjcard.2015.05.060"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American College of Cardiology","role":"isb"}],"recId":"320596249","disp":"Frequency of left ventricular hypertrophy in non-valvular atrial fibrillationThe American journal of cardiology","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 22.12.10","Ungezählte Beil.: Supplement"],"part":{"volume":"116","text":"116(2015), 6, Seite 877-882","extent":"6","year":"2015","issue":"6","pages":"877-882"},"pubHistory":["1.1958 -"],"title":[{"title_sort":"American journal of cardiology","subtitle":"official journal of the American College of Cardiology","title":"The American journal of cardiology"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["ed.-in-chief Simon Dack"]},"id":{"issn":["1879-1913"],"eki":["320596249"],"zdb":["2019595-3"]},"origin":[{"dateIssuedDisp":"1958-","dateIssuedKey":"1958","publisher":"Elsevier","publisherPlace":"Amsterdam [u.a.]"}]}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Proietti, Marco","given":"Marco","family":"Proietti"},{"family":"Marra","given":"Alberto M.","roleDisplay":"VerfasserIn","display":"Marra, Alberto M.","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Tassone, Eliezer Joseph","role":"aut","family":"Tassone","given":"Eliezer Joseph"},{"display":"De Vuono, Stefano","roleDisplay":"VerfasserIn","role":"aut","family":"De Vuono","given":"Stefano"},{"family":"Corrao","given":"Salvatore","display":"Corrao, Salvatore","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Paolo","family":"Gobbi","role":"aut","display":"Gobbi, Paolo","roleDisplay":"VerfasserIn"},{"given":"Francesco","family":"Perticone","role":"aut","display":"Perticone, Francesco","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Corazza, Gino Roberto","given":"Gino Roberto","family":"Corazza"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Basili, Stefania","given":"Stefania","family":"Basili"},{"roleDisplay":"VerfasserIn","display":"Lip, Gregory Y. H.","role":"aut","family":"Lip","given":"Gregory Y. H."},{"given":"Francesco","family":"Violi","role":"aut","roleDisplay":"VerfasserIn","display":"Violi, Francesco"},{"role":"aut","display":"Raparelli, Valeria","roleDisplay":"VerfasserIn","given":"Valeria","family":"Raparelli"}],"title":[{"title_sort":"Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation","title":"Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 16.07.2020"],"recId":"172492611X","language":["eng"]} | ||
| SRT | |a PROIETTIMAFREQUENCYO2520 | ||